Trending...
- Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
- OneVizion Launches Vera AI, Bringing Connected Operational Context to Infrastructure Teams
- Defense & Space Strategy Strengthens as New Leadership Builds on NASA Results and Expanding Multi-Orbit Opportunities for Ascent Solar Technologies
VANCOUVER, BC, Jan. 21, 2025 ~ Las Vegas, NV - Human in Motion Robotics, a global leader in robotic mobility and humanoid technology, has made a groundbreaking leap in the field of rehabilitation technology with their latest product, XoMotion™. This innovative medical exoskeleton was recently named the Top Robot at CES 2025 by USA Today.
CES 2025, held from January 7-10 in Las Vegas, brought together the brightest minds in technology to showcase cutting-edge innovations from around the world. Among these impressive displays was XoMotion, which received widespread recognition from attendees, media outlets, and industry leaders for its transformative potential to assist individuals with mobility impairments caused by spinal cord injuries, strokes, and other neurological conditions.
The success of Human in Motion Robotics' exhibition at CES 2025 was highlighted by several key achievements. XoMotion received accolades from visitors and industry leaders alike, including a CES 2025 Innovations Award that solidified its position as a shining example of human-centered technological innovation. Attendees were also able to experience firsthand the self-balancing, hands-free, and natural motion capabilities of XoMotion through product demonstrations. These demonstrations were attended by individuals with mobility challenges as well as therapists and physicians who were impressed by the exoskeleton's ability to empower users with independence and enhance care.
More on nvtip.com
Investors and partners were also engaged by the platform technology and multidisciplinary expertise of Human in Motion Robotics. This led to exciting opportunities for future growth and advancements for XoMotion beyond just rehabilitation purposes.
The event also marked another milestone for Human in Motion Robotics as they continue to make strides towards improving the lives of those with mobility impairments. The connections made during CES will drive future advancements and growth for the company.
One of the key highlights of the exhibition was meeting Chloë Angus, Product Ambassador & Director of Lived Experience at Human in Motion Robotics. Chloë's inspiring journey of overcoming adversity serves as a testament to the power of XoMotion. After a life-altering medical event, Chloë partnered with HMR to help develop XoMotion, leveraging her lived experience to ensure the exoskeleton truly addresses the needs of users.
For those interested in learning more about XoMotion and Human in Motion Robotics, interviews with Chloë or a full press kit can be requested by contacting Phil Astrachan, VP of Marketing at 415-310-7466.
XoMotion's innovative design and functionality redefine assistive technology. The exoskeleton provides hands-free, self-balancing support that mimics natural human movement, making it intuitive for patients to use while reducing the physical and cognitive strain on therapists.
More on nvtip.com
Some key features of XoMotion include its self-balancing capabilities, which ensure stability and safety during use with 12 high-performance actuators that replicate natural bipedal movement. It also allows for hands-free upper-body functionality, enhancing usability. The exoskeleton is capable of complex ambulatory tasks and offers true functionality in all directions. Designed to aid patients at various stages of recovery, including spinal cord injuries, strokes, and other neurological impairments, XoMotion is also therapist-friendly as it reduces physical strain on therapists and allows them to focus on patient care.
Human in Motion Robotics is committed to making XoMotion accessible to those who need it most. Currently available for acquisition by rehabilitation facilities in Canada, the device is also available for scientific investigators conducting rehabilitation or robotics research worldwide. Clinical trials are currently underway for FDA approval in the United States with plans to expand its reach to other global markets such as Europe and Asia.
For more information or to request a demonstration of XoMotion, please visit humaninmotion.com or contact Human in Motion Robotics directly through their website.
CES 2025, held from January 7-10 in Las Vegas, brought together the brightest minds in technology to showcase cutting-edge innovations from around the world. Among these impressive displays was XoMotion, which received widespread recognition from attendees, media outlets, and industry leaders for its transformative potential to assist individuals with mobility impairments caused by spinal cord injuries, strokes, and other neurological conditions.
The success of Human in Motion Robotics' exhibition at CES 2025 was highlighted by several key achievements. XoMotion received accolades from visitors and industry leaders alike, including a CES 2025 Innovations Award that solidified its position as a shining example of human-centered technological innovation. Attendees were also able to experience firsthand the self-balancing, hands-free, and natural motion capabilities of XoMotion through product demonstrations. These demonstrations were attended by individuals with mobility challenges as well as therapists and physicians who were impressed by the exoskeleton's ability to empower users with independence and enhance care.
More on nvtip.com
- Boston Industrial Solutions Introduces Personalized Printing Training
- Century Fasteners de Mexico Exhibiting at the 2026 Automotive & Aerospace Nearshoring Summit
- Retell AI White Label Platform for Agencies Launched by VoiceAIWrapper, With Branded Client Portals and No Per-Minute Markup
- FOCUS Names Mark Phillips Senior Vice President of Business Development
- Notaron Expands Online Notarization Access Following Wisconsin Approval
Investors and partners were also engaged by the platform technology and multidisciplinary expertise of Human in Motion Robotics. This led to exciting opportunities for future growth and advancements for XoMotion beyond just rehabilitation purposes.
The event also marked another milestone for Human in Motion Robotics as they continue to make strides towards improving the lives of those with mobility impairments. The connections made during CES will drive future advancements and growth for the company.
One of the key highlights of the exhibition was meeting Chloë Angus, Product Ambassador & Director of Lived Experience at Human in Motion Robotics. Chloë's inspiring journey of overcoming adversity serves as a testament to the power of XoMotion. After a life-altering medical event, Chloë partnered with HMR to help develop XoMotion, leveraging her lived experience to ensure the exoskeleton truly addresses the needs of users.
For those interested in learning more about XoMotion and Human in Motion Robotics, interviews with Chloë or a full press kit can be requested by contacting Phil Astrachan, VP of Marketing at 415-310-7466.
XoMotion's innovative design and functionality redefine assistive technology. The exoskeleton provides hands-free, self-balancing support that mimics natural human movement, making it intuitive for patients to use while reducing the physical and cognitive strain on therapists.
More on nvtip.com
- Wings Air Helicopters Selected to Support VIP Transportation for Resorts World in New York
- Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Houston This October
- The Social Capital Revolution Comes to Phoenix!
- Lawsuit Alleges American Deli Food Caused Severe Illness, Acute Kidney Failure, And Eight-day Hospitalization
- FBI/DoW plot uncovered to hurt Trump/Vance through encouraged "widespread" cybersecurity breaches and racketeering theft of $80m in USDA payments
Some key features of XoMotion include its self-balancing capabilities, which ensure stability and safety during use with 12 high-performance actuators that replicate natural bipedal movement. It also allows for hands-free upper-body functionality, enhancing usability. The exoskeleton is capable of complex ambulatory tasks and offers true functionality in all directions. Designed to aid patients at various stages of recovery, including spinal cord injuries, strokes, and other neurological impairments, XoMotion is also therapist-friendly as it reduces physical strain on therapists and allows them to focus on patient care.
Human in Motion Robotics is committed to making XoMotion accessible to those who need it most. Currently available for acquisition by rehabilitation facilities in Canada, the device is also available for scientific investigators conducting rehabilitation or robotics research worldwide. Clinical trials are currently underway for FDA approval in the United States with plans to expand its reach to other global markets such as Europe and Asia.
For more information or to request a demonstration of XoMotion, please visit humaninmotion.com or contact Human in Motion Robotics directly through their website.
0 Comments
Latest on nvtip.com
- Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
- OneVizion Launches Vera AI, Bringing Connected Operational Context to Infrastructure Teams
- P-Wave Press Announces Pushing the Wave 2025 by L.A. Davenport
- DONGSHENG Titanium Recycling: Promoting a Closed-Loop Cycle for High-End Titanium Materials
- French Camp Academy Releases New Video Inviting Individuals to Consider a Life of Service
- LET US READ Documentary on Dyslexia and Literacy to Screen at TCL Chinese 6 in Hollywood
- Back-to-College Organization Starts at Home with PODS® Las Vegas
- Don Barnhart Brings His NFTG Tour Home as Delirious Celebrates One Year at Silver Sevens
- Defense & Space Strategy Strengthens as New Leadership Builds on NASA Results and Expanding Multi-Orbit Opportunities for Ascent Solar Technologies
- STS Capital Partners is pleased to announce the appointment of Barry Brown as Vice President, Business Development
- Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
- Soft Water Nevada Announces Labor Day $995 Water Softener & Reverse Osmosis Special for Las Vegas Homeowners
- Boulder City Hospital Awarded $2.65+ Million Rural Health Transformation Initiative Grant
- Heritage at Manalapan Welcomes New Sales Team as Luxury Single-Family Home Community Continues to Grow
- Mandeville Pests May Pose Serious Health Risks for Your Family
- Strategic eMarketing Shortlisted for "Top Strategic Industrial Marketing Solutions 2026" Recognition
- NVision Optix Encourages Year-Round UV Eye Protection for Long-Term Vision Health
- Share your workplace safety solutions at 2027 Applied Ergonomics Conference
- Parents No Longer Have to Wait 3 Weeks for a Sleep Consultant: Nora Talks Tonight, Stays for 5 Days, Costs $89
- May The Worst Team Win! Loserball Kicks Off Another NFL Season of Hilarious Mayhem